Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-08-07

FDA Approved: TOLCAPONE — Original Application (Ingenus Pharmaceuticals, LLC)

View source ↗

Summary

FDA approves a new original application for Tolcapone from Ingenus Pharmaceuticals, expanding access to this COMT inhibitor for use in Parkinson's disease as ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tolcapone (tolcapone)

Snippet

ORIG AP for TOLCAPONE (TOLCAPONE)